Patent · US Active

Penem prodrugs

US7795244B2 · kind B2 · utility

0Cited by

7References

10Claims

0Family size

Assignee

PFIZER INC. · US

Inventors

Katherine E. Brighty · Groton, US
Anthony Marfat · Mystic, US
Dale M. McLeod · Ledyard, US
John O'Donnell · Blackley, GB

Key dates

Filing date	Jun 30, 2008
Grant date	Sep 14, 2010
Priority date	—
Expiry date	Mar 18, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Orally bioavailable prodrugs of sulopenem, e.g.,and solvates and hydrates thereof, preparation thereof, formulation thereof, and use to treat and prevent infection in mammals such as humans. This abstract is not limiting to the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.